BVMF/JNJB34 (BVMF/JNJB34)

Brazil Stock Exchange: BVMF/JNJB34 · BRL

R$96.0

+0.60 (+0.6%)· Recorded snapshot

Market cap	3.5T
Revenue (ttm)	516.5B
Net income (ttm)	83.7B
EPS (ttm)	R$2.35
P/E (trailing)	40.9x
P/E (forward)	23.8x
Dividend	R$1.19 (1.24%)
Volume	15,615
Beta	0.21

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 516.5B
Net income (ttm): 83.7B
EPS (ttm): R$2.35
P/E (trailing): 40.9x
P/E (forward): 23.8x
Market cap: 3.5T

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E23.8

P25 n/aP50 n/aP75 n/a

Trailing P/E40.9

P25 n/aP50 n/aP75 n/a

ROE20

P25 n/aP50 n/aP75 n/a

ROIC21.6

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All BVMF/JNJB34 indicators

Market & fundamental data

Available fields

255

Groups with data

Currency

USD

Showing 255 of 255 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	BRL
Country	United States
Country code	BR
Earnings date	2026-10-13
Employees	138,200
Employees change	6,200
Employees growth	4.7%
Enterprise value	BRL 3.6T
Exchange	Brazil Stock Exchange
Financial currency	USD
Financial report date	2026-09-27
First seen	2026-05-10
Fiscal year end	December
Founded	1886
Industry	Drug Manufacturers - General
Is primary listing	No
ISIN number	BRJNJBBDR002
Last earnings date	2026-10-13
Last refreshed	2026-10-28
Last stock split date	2021-01-27
Last stock split type	Forward
Market cap	BRL 3.5T
Next earnings date	2027-01-19
Price	BRL 96.00
Price currency	BRL
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-27
Symbol	bvmf/JNJB34
Website	https://www.jnj.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	46.5x
Average P/E ratio (3Y)	20.72x
Average P/E ratio (5Y)	22.21x
Earnings yield	2.45%
EV/Earnings	43.09x
EV/EBIT	25.53x
EV/EBITDA	19.43x
EV/FCF	33.68x
EV/Sales	6.79x
FCF / EV yield	2.97%
FCF yield	3.1%
Forward P/E	23.84x
Graham number	24.79565
Graham upside	-74.17%
Lynch fair value	BRL 11.61
Lynch upside	-87.9%
P/(FCF - SBC) ratio	34.71x
P/(OCF - SBC) ratio	26.9x
P/B ratio	8.16x
P/E ratio	40.89x
P/FCF ratio	32.31x
P/OCF ratio	25.43x
P/S ratio	6.7x
Price/EBITDA ratio	19.28x
Sector forward P/E	11.33x
Sector P/E	41.97x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	26.59%
EBITDA margin	34.73%
Effective tax rate	9.26%
FCF margin	20.15%
Gross margin	67.77%
Operating margin	26.59%
Pretax margin	17.86%
Profit margin	16.2%
Profit per employee	BRL 605,554
Profitable quarters	14
Profitable years	35
Revenue per employee	BRL 3.7M
ROA	8.46%
ROA (5Y)	8.04%
ROCE	18.6%
ROE	20.02%
ROE (5Y)	24.21%
ROIC	21.57%
ROIC (5Y)	23.67%
SBC / revenue	1.43%
Tax / revenue	1.65%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	-36.37%
EPS growth (Q)	-95.89%
EPS growth (QoQ)	-96.16%
EPS growth 10Y	1.46%
EPS growth 3Y	-20.75%
EPS growth 5Y	-0.32%
EPS growth years	1
FCF growth	5.07%
FCF growth (Q)	-20.64%
FCF growth (QoQ)	-12.84%
FCF growth 3Y	9.37%
FCF growth 5Y	-1.72%
Gross profit growth	6.88%
Gross profit growth (Q)	3.56%
Gross profit growth 3Y	5.04%
Gross profit growth 5Y	1.75%
Net income growth	-35.93%
Net income growth (Q)	-95.92%
Net income growth (QoQ)	-96.21%
Net income growth 3Y	-22.54%
Net income growth 5Y	-2.08%
Net income growth years	1
OCF growth	8.08%
OCF growth (Q)	-15.8%
OCF growth (QoQ)	-10.4%
OCF growth 10Y	4.28%
OCF growth 3Y	8.86%
OCF growth 5Y	0.11%
Operating income growth	7.65%
Operating income growth (Q)	-9.78%
Operating income growth 3Y	3.06%
Operating income growth 5Y	1.65%
Revenue growth	7.8%
Revenue growth (Q)	5.86%
Revenue growth (QoQ)	0.35%
Revenue growth 10Y	3.33%
Revenue growth 3Y	5.87%
Revenue growth 5Y	1.67%
Revenue growth quarters	13
Revenue growth years	4

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	BRL -29B
Depreciation and amortization	BRL 43.3B
EBIT	BRL 137.3B
EBITDA	BRL 179.4B
EPS	BRL 2.35
Financing cash flow	BRL -94.4B
Free cash flow	BRL 107.1B
Free cash flow minus SBC	BRL 99.7B
Gross profit	BRL 350.1B
Income taxes	BRL 8.5B
Investing cash flow	BRL -48.6B
Net borrowing	BRL -4.2B
Net cash flow	BRL -6.9B
Net income	BRL 83.7B
Operating cash flow minus SBC	BRL 128.6B
Operating income	BRL 137.3B
Revenue	BRL 516.5B
Stock-based compensation	BRL 7.4B

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	5.03
Book value per share	BRL 176.11
Debt / EBITDA	1.29
Debt / equity	0.55
Debt / FCF	2.17
Goodwill	BRL 259.3B
Interest coverage	26.84
Long-term assets	BRL 725.1B
Long-term liabilities	BRL 306B
Net cash (debt)	BRL -142.6B
Net cash / market cap	-4.12%
Net debt / EBITDA	0.79
Net debt / equity	0.34
Net debt / FCF	1.33
Piotroski F-Score	6
Property, plant and equipment	BRL 128.9B
Shareholders' equity	BRL 423.9B
Tangible book value	BRL -70.7B
Tangible book value per share	BRL -29.37
Total assets	BRL 1T
Total cash	BRL 89.6B
Total debt	BRL 232.2B
Total liabilities	BRL 602.6B
WACC	5.17%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.51
Current assets	BRL 301.4B
Current liabilities	BRL 296.6B
Current ratio	1.02
Inventory turnover	2.17
Net working capital	BRL -38.9B
Quick ratio	0.65
Working capital	BRL 4.6B
Working capital turnover	222.82

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-0.8%
Dividend growth	3.51%
Dividend growth (10Y)	5.77%
Dividend growth (3Y)	4.01%
Dividend growth (5Y)	5.38%
Dividend growth years	9
Dividend payment date	2026-12-17
Dividend payment years	16
Dividend payout frequency	Quarterly
Dividend per share	BRL 1.19
Dividend yield	1.24%
Ex-dividend date	2026-11-24
Last dividend	BRL 0.06
Payout ratio	79.01%
Shareholder yield	0.44%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	300.38%
10Y return CAGR	16.96%
10Y total return	379%
150-day SMA	BRL 84.89
1D price change	0.63%
1M price change	1.92%
1M total return	1.92%
1W price change	12.61%
1W total return	12.61%
1Y price change	40.45%
1Y return CAGR	42.6%
1Y total return	42.56%
20-day SMA	BRL 88.32
200-day SMA	BRL 84.11
3M price change	7.65%
3M total return	7.99%
3Y price change	93.12%
3Y return CAGR	26.92%
3Y total return	104.47%
50-day SMA	BRL 90.84
50-day SMA vs 200-day SMA	50over200
52-week high	BRL 100.24
52-week high date	2026-10-26
52-week low	BRL 65.65
52-week low date	2025-11-10
5Y price change	55.74%
5Y return CAGR	11.31%
5Y total return	70.89%
6M price change	25.49%
6M total return	26.38%
All-time high	BRL 100.24
All-time high date	2026-10-26
All-time low	BRL 9.16
All-time low date	2012-09-04
Average true range (ATR)	BRL 3.04
Average volume	10.5K
Beta (5Y)	0.21
Change from 52-week high	-4.23%
Change from 52-week low	46.23%
Change from all-time high	-4.23%
Change from all-time low	947.92%
Change from open	0.05%
Day's gap	0.58%
Dollar volume	BRL 1.5M
High price	BRL 96.00
Low price	BRL 93.97
Monthly RSI	73.81
Open price	BRL 95.95
Position in 52-week range	100%
Previous close	BRL 95.40
Price vs 150-day SMA	13.08%
Price vs 20-day SMA	8.7%
Price vs 200-day SMA	14.14%
Price vs 50-day SMA	5.68%
Relative volume	1.49
RSI	66.16
Sharpe ratio	1.3
Sharpe ratio (3Y)	0.9
Sharpe ratio (5Y)	0.44
Sortino ratio	2.28
Sortino ratio (3Y)	1.61
Sortino ratio (5Y)	0.91
Volume	15.6K
Weekly RSI	62.4
YTD price change	26.87%
YTD total return	28.22%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	2.4B
Shares change (QoQ)	0.35%
Shares change (YoY)	0.8%
Shares held by insiders	0.04%
Shares held by institutions	76.32%
Short ratio	2.4 days

Deeper analysis on BVMF/JNJB34

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BVMF/JNJB34 report

Is a complete BVMF/JNJB34 research report available?

No complete published report is available for bvmf/JNJB34 (BVMF/JNJB34) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BVMF/JNJB34 (BVMF/JNJB34)

Price

Financial snapshot

Fair-value bridge

Latest news · BVMF/JNJB34

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BVMF/JNJB34 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BVMF/JNJB34

Frequently asked questions